This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Fhärm, E. Articles by Weinehall, L. Search for Related Content PubMed PubMed Citation Articles by Fhärm, E. Articles by Weinehall, L. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CHOLESTEROL Medline Plus Health Information Diabetes Social Bookmarking                   What's this?

Guidelines improve general trend of lowered cholesterol levels in type 2 diabetes patients in spite of low adherence

Family Medicine, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden, eva.fharm{at}vll.se

O. Rolandsson

Family Medicine, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden,

L. Weinehall

Epidemiology and Public Health Sciences, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden, and, Research Department, National Institute of Public Health - Sweden, Stockholm, Sweden

Background: New guidelines were introduced in Sweden in 1999 to reduce the risk of cardiovascular disease among diabetes patients. The impact of the new guidelines on lipid levels in a diabetes patient population has not been extensively studied. Our aim was to study whether the introduction of treatment goals for dyslipidaemia was reflected in lower cholesterol levels in patients with diabetes in a general population. Methods: In a population of 59,338 individuals, 971 (1.6%) had diabetes. All subjects were 40, 50 or 60 years of age and participated in the Vasterbotten Intervention Programme in 1995-2004. Cholesterol levels and use of lipid-lowering drugs were measured, and trends in cholesterol levels were analysed before and after the guidelines were introduced in 1999. Results: In this effectiveness study, there was a marked decrease in mean plasma total cholesterol levels among patients with diabetes (5.79 (± 1.21) mmol/1 in 1995-1999 and 5.07 (± 1.00) mmol/1 in 2000-2004 (p<0.001)) as well as in the non-diabetic population (5.79 (±1.15) mmol/1 and 5.41 (±1.07) mmol/1 (p<0.001)). The trend in diabetes patients was influenced by increased use of lipid-lowering agents, even though only 25.3% (male/female 26.8%/23.2%) of the diabetes patients received lipid-lowering treatment after the introduction of the new guidelines. Conclusions: Since the introduction of the guidelines, an increasing number of diabetes patients are receiving lipid-lowering drugs, which enhance a strong general trend of lowered cholesterol levels. Yet, the vast majority of diabetes patients with hypercholesterolaemia still do not receive medical treatment in accordance with the guidelines.

Key Words: Antilipaemic agents • diabetes mellitus • effectiveness • epidemiology • guideline adherence • hypercholesterolaemia

Scandinavian Journal of Public Health, Vol. 36, No. 1, 69-75 (2008)
DOI: 10.1177/1403494807085374


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. Fharm, O. Rolandsson, and E. E Johansson 'Aiming for the stars'--GPs' dilemmas in the prevention of cardiovascular disease in type 2 diabetes patients: focus group interviews Fam. Pract., April 1, 2009; 26(2): 109 - 114. [Abstract] [Full Text] [PDF]